Cargando…
Obesity and triple‐negative‐breast‐cancer: Is apelin a new key target?
Epidemiological studies have shown that obese subjects have an increased risk of developing triple‐negative breast cancer (TNBC) and an overall reduced survival. However, the relation between obesity and TNBC remains difficult to understand. We hypothesize that apelin, an adipokine whose levels are...
Autores principales: | Gourgue, Florian, Mignion, Lionel, Van Hul, Matthias, Dehaen, Natacha, Bastien, Estelle, Payen, Valery, Leroy, Baptiste, Joudiou, Nicolas, Vertommen, Didier, Bouzin, Caroline, Delzenne, Nathalie, Gallez, Bernard, Feron, Olivier, Jordan, Bénédicte F., Cani, Patrice D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520321/ https://www.ncbi.nlm.nih.gov/pubmed/32681609 http://dx.doi.org/10.1111/jcmm.15639 |
Ejemplares similares
-
Acetate: Friend or foe against breast tumour growth in the context of obesity?
por: Yelek, Caner, et al.
Publicado: (2020) -
Metabolic imaging using hyperpolarized (13)C‐pyruvate to assess sensitivity to the B‐Raf inhibitor vemurafenib in melanoma cells and xenografts
por: Acciardo, Stefania, et al.
Publicado: (2019) -
Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas
por: Acciardo, Stefania, et al.
Publicado: (2018) -
Impact of Inhibition of the Mitochondrial Pyruvate Carrier on the Tumor Extracellular pH as Measured by CEST-MRI
por: Buyse, Chloé, et al.
Publicado: (2021) -
Tumor apelin and obesity are associated with reduced neoadjuvant chemotherapy response in a cohort of breast cancer patients
por: Gourgue, Florian, et al.
Publicado: (2021)